HomeNPCE • NASDAQ
add
Neuropace Inc
Previous close
$14.09
Day range
$14.20 - $14.52
Year range
$7.56 - $18.97
Market cap
488.51M USD
Avg Volume
206.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.96%
1.05%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 26.59M | 23.86% |
Operating expense | 22.34M | 12.62% |
Net income | -2.73M | 48.02% |
Net profit margin | -10.26 | 58.05% |
Earnings per share | -0.08 | 55.56% |
EBITDA | -1.69M | 53.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.06M | 15.74% |
Total assets | 105.56M | 11.54% |
Total liabilities | 86.53M | -0.12% |
Total equity | 19.03M | — |
Shares outstanding | 33.67M | — |
Price to book | 24.72 | — |
Return on assets | -4.15% | — |
Return on capital | -4.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.73M | 48.02% |
Cash from operations | 506.00K | 110.55% |
Cash from investing | -97.00K | -104.95% |
Cash from financing | 635.00K | -25.12% |
Net change in cash | 1.04M | 152.52% |
Free cash flow | 1.43M | 146.26% |
About
Founded
1997
Website
Employees
209